Single-cell longitudinal analysis of regeneration in human pancreatic slices
人胰腺切片再生的单细胞纵向分析
基本信息
- 批准号:10490330
- 负责人:
- 金额:$ 38.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-20 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAntibodiesArchitectureB-LymphocytesBMPR1A geneBeta CellBioinformaticsBiological ProcessBiomedical EngineeringCellsCharacteristicsCoupledDevelopmentDiabetes MellitusDissectionDuct (organ) structureDuctal Epithelial CellEndocrineEventExposure toGoalsHumanImmuneIn VitroInflammationInsulin-Dependent Diabetes MellitusLeadershipMapsMediatingMissionModelingMusNational Institute of Diabetes and Digestive and Kidney DiseasesNatural regenerationNatureNon-Insulin-Dependent Diabetes MellitusOrganPancreasPancreatic DiseasesPancreatic ductPathway interactionsPerinatalPopulationProcessProliferatingPublic HealthRegenerative capacityRegenerative researchResearchResearch DesignResearch InstituteResolutionSignal TransductionSliceSorting - Cell MovementSourceStressStructure of beta Cell of isletSurfaceSystemTechniquesTestingTherapeuticTimeTissuesTransgenic OrganismsTransplantationTreesVisualizationWithdrawalXenograft procedurebasebone morphogenetic protein receptorscell regenerationcell typedesigndevelopmental plasticitydiabetes mellitus therapydiabeticdifferential expressionexperimental studyhuman modelin vivoin vivo regenerationisletlongitudinal analysismethod developmentmouse modelmoviemultidisciplinarynew technologynovelnovel therapeutic interventionnovel therapeuticsorgan on a chipprogenitorreal time monitoringregeneration potentialresponsesingle cell analysisstem cellssuccesstooltranscriptomicsvirtual
项目摘要
PROJECT SUMMARY
We have described a subpopulation of human pancreatic ductal cells with progenitor-like characteristics.
These cells can be sorted using antibodies against the BMP receptor 1A (ALK3bright+) and P2RY1, a surrogate
surface marker for PDX1 identified by our team. ALK3bright+/P2RY1+ cells proliferate when exposed to BMP-7,
and differentiate into all adult pancreatic cell types, including functional β-cells, upon BMP-7 withdrawal.
scRNAseq of the ALK3bright+ fraction of human pancreatic donors confirmed the existence of clusters with
progenitor-like features, with substantial evidence suggesting that such features may be acquired by de-
differentiation. When transplanted into immune-deficient mice, sorted cell populations enriched in markers
differentially expressed in these clusters self-organize into ‘micro-pancreata’ with native-like cytoarchitecture and
functional endocrine cells. More recently, we have developed the means to study the dynamic processes of
progenitor cell-dependent regeneration using human pancreatic slices (HPSs). We have achieved functional
long-term (>10d) culture of HPSs, which allows for the longitudinal tracking of β-cell regeneration in a setting
that is widely considered the closest approximation in vitro to a native pancreas. BMP signaling-dependent
regeneration was established in slices from healthy and, more importantly, T1D and T2D donors.
Numerous single-cell analyses of the pancreas, included our own, support the emerging view that specific
lineages are in a state of flux between differentiation stages. However, all these analyses only offer a snapshot
of the tissue at any given time point. Conclusions about potential developmental/regeneration paths are
exclusively based on bioinformatics inferences. We hypothesize that the combination of long-term organotypic
culture with lineage-tracing in vitro and sequential single-cell analyses will allow us, for the first time, to
dynamically map cell fate changes –e.g., by conducting longitudinal scRNAseq of slices from the same donor
across multiple time points after BMP-7 addition. Furthermore, we contend that this system will enable the real-
time visualization and in-depth, single-cell resolution study of potential de-differentiation events, should they
happen in response to different sources of stress in human slices. These approaches offer a wealth of new
research possibilities that were downright unfeasible prior to the development of these methods. Our research
design is expected to help us realize the full potential of single-cell transcriptomics to unveil dynamic biological
processes, model human pancreatic disease, and, ultimately, enable the development of novel therapeutic
approaches to induce regeneration. We will test the above hypotheses by pursuing the following specific aims:
(1) Longitudinal scRNAseq of same-donor T1D/T2D HPSs following stimulation of the BMP pathway. (2) Study
of the effect of stress, inflammation and de-differentiation on BMP-7-mediated induction of β-cell formation in
HPSs; (3) Functional characterization of neogenic β-cells through “slice-on-a-chip” approaches; and (4)
Determination of in vivo regeneration potential of progenitor cells sorted from healthy and T1D/T2D donors using
a xenotransplantation model.
项目摘要
我们描述了一个具有祖细胞样特征的人胰腺导管细胞亚群。
这些细胞可以使用针对BMP受体1A(ALK 3bright+)和P2 RY 1(替代物)的抗体进行分选。
PDX 1的表面标记物。当暴露于BMP-7时,ALK 3bright +/P2 RY 1+细胞增殖,
并在BMP-7撤除后分化成所有成体胰腺细胞类型,包括功能性β细胞。
人胰腺供体的ALK 3bright+级分的scRNAseq证实了存在簇,
祖细胞样特征,有大量证据表明,这些特征可能是通过去-
分化当移植到免疫缺陷小鼠体内时,
在这些簇中差异表达的细胞自组织成具有天然样细胞结构的“微胰腺”,
功能性内分泌细胞最近,我们已经开发出了研究
使用人胰腺切片(HPS)的祖细胞依赖性再生。我们已经实现了功能性
HPS的长期(> 10天)培养,其允许在环境中纵向跟踪β细胞再生
这被广泛认为是体外最接近天然胰腺的。BMP信号依赖性
在来自健康供体,更重要的是T1 D和T2 D供体的切片中建立了再生。
包括我们自己在内的许多胰腺单细胞分析支持了一种新的观点,
谱系在分化阶段之间处于流动状态。然而,所有这些分析只提供了一个快照,
在任何给定的时间点。关于潜在发育/再生途径的结论是
完全基于生物信息学推论。我们假设长期的器官型
体外谱系追踪培养和连续单细胞分析将使我们首次能够
动态映射细胞命运变化-例如,通过对来自同一供体的切片进行纵向scRNAseq,
在BMP-7添加后的多个时间点。此外,我们认为,这一制度将使真实的-
时间可视化和深入的,潜在的去分化事件的单细胞分辨率研究,他们应该
在人体切片中,不同的压力源会产生不同的反应。这些方法提供了大量新的
在这些方法发展之前完全不可行的研究可能性。我们的研究
设计有望帮助我们实现单细胞转录组学的全部潜力,
过程,模拟人类胰腺疾病,并最终能够开发新的治疗方法,
诱导再生的方法。我们将通过追求以下具体目标来检验上述假设:
(1)刺激BMP途径后相同供体T1 D/T2 D HPS的纵向scRNAseq。(2)研究
研究了应激、炎症和去分化对BMP-7介导的β细胞形成的影响,
(3)通过“芯片上切片”方法对新生β细胞进行功能表征;以及(4)
使用流式细胞仪测定从健康和T1 D/T2 D供体分选的祖细胞的体内再生潜力
异种移植模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Juan Dominguez-Bendala其他文献
Juan Dominguez-Bendala的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Juan Dominguez-Bendala', 18)}}的其他基金
Single-cell longitudinal analysis of regeneration in human pancreatic slices
人胰腺切片再生的单细胞纵向分析
- 批准号:
10336196 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
Single-cell longitudinal analysis of regeneration in human pancreatic slices
人胰腺切片再生的单细胞纵向分析
- 批准号:
10677724 - 财政年份:2021
- 资助金额:
$ 38.38万 - 项目类别:
HIGH-RESOLUTION CHARACTERIZATION OF HUMAN DUCTAL PROGENITOR CELLS AND THEIR REGENERATION POTENTIAL
人类导管祖细胞及其再生潜力的高分辨率表征
- 批准号:
10252070 - 财政年份:2018
- 资助金额:
$ 38.38万 - 项目类别:
HIGH-RESOLUTION CHARACTERIZATION OF HUMAN DUCTAL PROGENITOR CELLS AND THEIR REGENERATION POTENTIAL
人类导管祖细胞及其再生潜力的高分辨率表征
- 批准号:
9788440 - 财政年份:2018
- 资助金额:
$ 38.38万 - 项目类别:
HIGH-RESOLUTION CHARACTERIZATION OF HUMAN DUCTAL PROGENITOR CELLS AND THEIR REGENERATION POTENTIAL
人类导管祖细胞及其再生潜力的高分辨率表征
- 批准号:
10186697 - 财政年份:2018
- 资助金额:
$ 38.38万 - 项目类别:
Preclinical characterization of THR-123 to induce pancreatic beta cell regeneration (Phase I)
THR-123 诱导胰腺 β 细胞再生的临床前表征(第一阶段)
- 批准号:
9465072 - 财政年份:2017
- 资助金额:
$ 38.38万 - 项目类别:
technologyIn vitro maturation of BMP-7-responsive pancraeatic beta cell progenitors by oxygen modulation
技术通过氧调节使 BMP-7 反应性胰腺 β 细胞祖细胞体外成熟
- 批准号:
9344589 - 财政年份:2015
- 资助金额:
$ 38.38万 - 项目类别:
A perfluorocarbon-based culture device for beta cell biology applications (Phase
用于 β 细胞生物学应用的基于全氟化碳的培养装置(Phase
- 批准号:
8487397 - 财政年份:2009
- 资助金额:
$ 38.38万 - 项目类别:
A perfluorocarbon-based culture device for beta cell biology applications (Phase
用于 β 细胞生物学应用的基于全氟化碳的培养装置(Phase
- 批准号:
8314435 - 财政年份:2009
- 资助金额:
$ 38.38万 - 项目类别:
Somatic cell reprogramming by protein transduction
通过蛋白质转导进行体细胞重编程
- 批准号:
7761208 - 财政年份:2009
- 资助金额:
$ 38.38万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 38.38万 - 项目类别:














{{item.name}}会员




